Cencora (COR) Gains from Investment Securities (2025 - 2026)
Cencora (COR) posted Gains from Investment Securities of $55.4 million for Q1 2026, up 31.58% on a QoQ basis from $42.1 million in Q4 2025, and up 48.01% year-over-year from $37.5 million in Q1 2025.
Cencora (COR) Gains from Investment Securities (2025 - 2026) Analysis & Trends
Cencora's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $55.4 million for Q1 2026.
- Quarterly Gains from Investment Securities rose 48.01% year-over-year to $55.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $154.6 million (up 312.82% YoY) and the FY2025 annual result came in at $121.7 million, changed N/A from the prior year.
- Gains from Investment Securities was $55.4 million for Q1 2026 at Cencora, up from $42.1 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $55.4 million in Q1 2026 and bottomed at $19.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.45 Mn |
| Mar 31, 2026 | 55.45 Mn |
| Dec 31, 2025 | 42.14 Mn |
| Dec 31, 2025 | 42.14 Mn |
| Sep 30, 2025 | 19.60 Mn |
| Sep 30, 2025 | 19.60 Mn |
| Jun 30, 2025 | 37.46 Mn |
| Jun 30, 2025 | 37.46 Mn |
| Mar 31, 2025 | 37.46 Mn |
| Mar 31, 2025 | 37.46 Mn |